admin

The recent plunge of PDD’s stock by almost 30% following disappointing quarterly results serves as a stark reminder of the changing dynamics within China’s consumer market. The era of double-digit growth that once characterized the sector seems to be fading into the past, with no immediate signs of a turnaround in sight. Despite this overarching
0 Comments
The aviation industry has seen a significant shift in priorities among airlines in the wake of the pandemic. Previously focused on expanding their fleets with new aircraft, many carriers are now deferring deliveries and cutting back on growth plans to save money and return to profitability. This change in strategy is particularly evident among cash-strapped
0 Comments
The latest decision by the local power regulator in Brazil, Aneel, to impose an additional charge on electricity bills due to low reservoir levels at hydroelectric plants has raised concerns among Brazilians. This move comes at a time when the country is experiencing a dry season and has led to consumers having to pay more
0 Comments
Alibaba, one of China’s tech giants, has recently completed a three-year regulatory “rectification” process imposed by the country’s market regulator. This process was initiated in response to an antitrust fine issued to Alibaba in 2021 due to monopolistic practices. The State Administration for Market Regulation (SAMR) in China confirmed that Alibaba has successfully addressed the
0 Comments
In recent years, Chinese lenders have played a significant role in providing loans to African countries, fueling infrastructure development and economic growth on the continent. A recent independent study has revealed some interesting trends in Chinese lending to Africa, indicating a shift in China’s strategy and priorities. While Chinese lending to Africa saw a significant
0 Comments
The Food and Drug Administration recently gave its approval for Novavax’s updated protein-based Covid vaccine, allowing for emergency use in individuals aged 12 and over. This move opens up the competition in the market, pitting Novavax against the well-known Pfizer and Moderna vaccines this coming fall and winter. Novavax’s vaccine is specifically designed to target
0 Comments